Tage Honore - Mar 15, 2023 Form 3 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
Director
Signature
/s/ Tage Honore
Stock symbol
VNDA
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
3
Date filed
3/17/2023, 04:49 PM
Next filing
Jun 12, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.